Reply:

References

1. 1.↵
   1. Agosta F,
   2. Rovaris M,
   3. Pagani E,
   4. et al

   . Magnetization transfer MRI metrics predict the accumulation of disability 8 years later in patients with multiple sclerosis. Brain 2006;129:2620–27

   Abstract/FREE Full Text
2. 2.↵
   1. Rovaris M,
   2. Agosta F,
   3. Sormani MP,
   4. et al

   . Conventional and magnetization transfer MRI predictors of clinical multiple sclerosis evolution: a medium-term follow-up study. Brain 2003;126:2323–32. Epub 2003 Aug 2322

   Abstract/FREE Full Text
3. 3.↵
   1. Fisniku LK,
   2. Brex PA,
   3. Altmann DR,
   4. et al

   . Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis. Brain 2008;131:808–17

   Abstract/FREE Full Text
4. 4.↵
   1. Kornek B,
   2. Lassmann H

   . Axonal pathology in multiple sclerosis: a historical note. Brain Pathol 1999;9:651–56

   PubMedWeb of Science
5. 5.↵
   1. Rocca MA,
   2. Mezzapesa DM,
   3. Falini A,
   4. et al

   . Evidence for axonal pathology and adaptive cortical reorganization in patients at presentation with clinically isolated syndromes suggestive of multiple sclerosis. Neuroimage 2003;18:847–55

   CrossRefPubMedWeb of Science
6. 6.↵
   1. Filippi M,
   2. Rovaris M,
   3. Inglese M,
   4. et al

   . Interferon beta-1a for brain tissue loss in patients at presentation with syndromes suggestive of multiple sclerosis: a randomised, double-blind, placebo-controlled trial. Lancet 2004;364:1489–96

   CrossRefPubMedWeb of Science
7. 7.↵
   1. Barkhof F,
   2. Filippi M,
   3. Miller DH,
   4. et al

   . Comparison of MR imaging criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain 1997;120:2059–69

   Abstract/FREE Full Text
8. 8.↵
   1. Kirov I,
   2. Patil V,
   3. Babb JS,
   4. et al

   . MR spectroscopy indicates diffuse multiple sclerosis activity during remission. J Neurol Neurosurg Psychiatry 2009;80:1330–36

   Abstract/FREE Full Text